March 2017 ARTICLE LIST >>
PharmaTutor (March - 2017)
ISSN: 2347 - 7881
(Volume 5, Issue 3)
Received On: 19/10/2016; Accepted On: 24/11/2016; Published On: 01/03/2017
AUTHORS:
Akanksha Bhandari1, Nitisha Bhandari2*
1Shri Guru Ram Rai Institute of Technology and Science, Patel Nagar, Dehradun
2Graphic Era University, Dehradun, India
* nitishabhandari89@gmail.com
ABSTRACT: Interactions of proteins could be resulted from homodimerisation or heterodimerisation. But these are quite specific and always selective in nature and act only on particular set of class of proteins, which provide substantial target behaviour to a drug designer. Here in this paper, provided a commentary based review compiling the short notes information provided on protein proteins interactions, by “Catherine Royer”.
How to cite this article: Bhandari A, Bhandari N;Protein-protein surface interactions: Constrains of homologous versus heterogeneous domains; PharmaTutor; 2017; 5(3); 9-14
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Negi A, Gill B: Success stories of enolate form of drugs. PharmaTutor 2013, 1(2):45-53.
2. Singla R, Negi A, Singh V: Indole based alkaloid in cancer: an overview. PharmaTutor Mag 2014, 2:76-82.
3. Singla R, Singh V, Negi A: Synthetic Indole Alkaloids in Cancer: An Overview.
4. Negi A: Anaphylactic Shock: Shocking Error of Immune System! PharmaTutor 2013, 1(2):12-16.
5. Negi A, Pandey AK, Joshi G, Agnihotri V: Impact of protein tyrosine phosphate on cancer metastasis: an overview. World J Pharm Res Technol 2013, 1(2):118-130.
6. Negi A, Gill B, Anand S: Tilling: versatile reverse genetic tool. PharmaTutor 2014, 2(1):26-32.
7. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C: STRING v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic acids research 2013, 41(D1):D808-D815.
8. Zhou J, Reidy M, O’Reilly C, Jarikote DV, Negi A, Samali A, Szegezdi E, Murphy PV: Decorated Macrocycles via Ring-Closing Double-Reductive Amination. Identification of an Apoptosis Inducer of Leukemic Cells That at Least Partially Antagonizes a 5-HT2 Receptor. Organic letters 2015, 17(7):1672-1675.
9. Paoli M, Liddington R, Tame J, Wilkinson A, Dodson G: Crystal structure of T state haemoglobin with oxygen bound at all four haems. Journal of molecular biology 1996, 256(4):775-792.
10. Negi A, Ramarao P, Kumar R: Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents. Mini reviews in medicinal chemistry 2013, 13(5):653-681.
11. Tong L, Warren TC, Lukas S, Schembri-King J, Betageri R, Proudfoot JR, Jakes S: Carboxymethyl-phenylalanine as a replacement for phosphotyrosine in SH2 domain binding. Journal of Biological Chemistry 1998, 273(32):20238-20242.
12. Narula S, Yuan R, Adams S, Green O, Green J, Philips T, Zydowsky L, Botfield M, Hatada M, Laird E: Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Structure 1995, 3(10):1061-1073.
13. Renzoni D, Pugh D, Siligardi G, Das P, Morton C, Rossi C, Waterfield M, Campbell I, Ladbury J: Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase. Biochemistry 1996, 35(49):15646-15653.
14. Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R: Crystal structures of a complexed and peptide-free membrane protein–binding domain: molecular basis of peptide recognition by PDZ. Cell 1996, 85(7):1067-1076.
15. Hammarström A, Berndt KD, Sillard R, Adermann K, Otting G: Solution structure of a naturally-occurring zinc-peptide complex demonstrates that the N-terminal zinc-binding module of the Lasp-1 LIM domain is an independent folding unit. Biochemistry 1996, 35(39):12723-12732.
16. Glover JM, Harrison SC: Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA. 1995.
17. Ghosh G, Van Duyne G, Ghosh S, Sigler PB: Structure of NF-κB p50 homodimer bound to a κB site. 1995.
18. Schwabe JW, Chapman L, Finch JT, Rhodes D: The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993, 75(3):567-578.
.png)
